Look for:

Our offer for

KONINKLIJKE PHILIPS NV


ISIN:
NL0000009538
WKN:
0953

2023/03/24 17:35:39
Price
14.80 EUR
Difference -3.17% (-0.48)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeEuronext Amsterdam
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)13,103 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)14.70 EUR (1,700)
Ask (Ask size)14.85 EUR (200)
Open15.248 EUR
High15.312 EUR
Low14.542 EUR
Close (prev. day)15.284 EUR
VWAP14.901231 EUR
Volume (pcs)5,125,488
Trading volume76,376,082.00
Number of trades12,841
Last size4,034

Futures and Options

Related Futures53
Related Options-

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2023/03/24 17:35:39
Price
14.80 EUR
Difference -3.17% (-0.48)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeEuronext Amsterdam
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)13,103 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)14.70 EUR (1,700)
Ask (Ask size)14.85 EUR (200)
Open15.248 EUR
High15.312 EUR
Low14.542 EUR
Close (prev. day)15.284 EUR
VWAP14.901231 EUR
Volume (pcs)5,125,488
Trading volume76,376,082.00
Number of trades12,841
Last size4,034

Performance and Risk

6m1Y3Y
Perf (%)-9.20%-45.23%-54.91%
Perf (abs.)-1.50-12.22-18.02
Beta1.351.220.94
Volatility43.6542.0034.29
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)15.14 EUR (2,909,396)
Ø price 30 days | Ø volume 30 days (pcs.)15.58 EUR (2,946,257)
Ø price 100 days | Ø volume 100 days (pcs.)14.86 EUR (3,838,150)
Ø price 250 days | Ø volume 250 days (pcs.)17.95 EUR (3,796,011)
YTD High | date16.86 EUR (2023/01/30)
YTD Low | date14.09 EUR (2023/01/02)
52 Weeks High | date29.00 EUR (2022/04/22)
52 Weeks Low | date12.13 EUR (2022/11/03)

All listings for KONINKLIJKE PHILIPS NV

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/03/2417:3514.668 EUR0.70145
Vienna Stock Exchange2023/03/2417:0214.888 EUR0.0818
Tradegate2023/03/2422:0215.128 EUR0.4492
Stuttgart2023/03/2409:0315.136 EUR0.003
SIX Swiss Exchange2022/06/0215:2047.0683 CHF0.001
Munich2023/03/2408:0015.208 EUR0.001
London Stock Exchange European Trade Reporting2023/03/2417:3014.785 EUR0.213
Hanover2023/03/2408:0115.208 EUR0.001
Hamburg2023/03/2415:5115.12 EUR0.012
Frankfurt2023/03/2421:3715.16 EUR0.0211
FINRA other OTC Issues2023/03/2418:5216.046 USD2.294
Euronext Milan MTF Trading After Hours2023/02/1320:1215.704 EUR0.001
Euronext Milan MTF GLobal Equity Market2023/03/2417:3514.68 EUR0.049
Euronext Amsterdam2023/03/2417:3514.80 EUR76.3812,841
Duesseldorf2023/03/2421:0014.958 EUR0.0010
Berlin2023/03/2421:5215.132 EUR0.0016
BX Swiss2023/02/2118:0015.645 CHF0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2324&ID_TYPE_IMAGE_LOGO=2

Contact Details

KONINKLIJKE PHILIPS NV
- -
Philips Center, Amstelplein 2 - 1096 BC Amsterdam
Telefon: +31-20-597-77-77
Fax: +
E-mail: -

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Company Profile

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Members of Management Board

Frans von HoutenChairman of Managing Board
Abhijit BhattacharyaMember of Executive Committee
Andy HoMember of Executive Committee
Bert van MeursMember of Executive Committee
Daniela SeabrookMember of Executive Committee
Deeptha KhannaMember of Executive Committee
Edwin PaalvastMember of Executive Committee
Kees WesdorpMember of Executive Committee
Marnix van GinnekenMember of Executive Committee
Roy JakobsMember of Executive Committee
Shez PartoviMember of Executive Committee
Sophie BechuMember of Executive Committee
Vitor RochaMember of Executive Committee

Board of directors

Feike SijbesmaChairman of Supervisory Board
A. HarrisonMember of Supervisory Board
Paulus StoffelsMember of Supervisory Board
David PyottMember of Supervisory Board
Herna VerhagenMember of Supervisory Board
Indra Krishnamurthy NooyiMember of Supervisory Board
Mary DohertyMember of Supervisory Board
Peter D. LöscherMember of Supervisory Board
Sanjay PoonenMember of Supervisory Board
Sock Koong ChuaMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer